# FILKRI

NDC: 69448-009
Generic name: filgrastim-laha
Labeler / Manufacturer: Accord BioPharma Inc.,
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20260715

FDA application: BLA761027

## Active ingredients

- FILGRASTIM: 480 ug/.8mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69448-009"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69448-009
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9c2f9573-08fd-43be-a489-8a5e5d8ab2ff